Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333].
- DOI
- 10.1016/j.carbpol.2026.125444
- Published
- 2026 Aug 15
- Container
- Carbohydrate polymers
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.carbpol.2026.125444,
title = {Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333].},
author = {Adachi T and Khan NF and Michihara A and Kaneko R and Mizukai Y and Maezaki Y and Kawano K and Kadowaki D and Otagiri M and Anraku M},
year = {2026},
journal = {Carbohydrate polymers},
doi = {10.1016/j.carbpol.2026.125444},
url = {https://doi.org/10.1016/j.carbpol.2026.125444}
}RIS
TY - JOUR TI - Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333]. AU - Adachi T AU - Khan NF AU - Michihara A AU - Kaneko R AU - Mizukai Y AU - Maezaki Y AU - Kawano K AU - Kadowaki D AU - Otagiri M AU - Anraku M PY - 2026 JO - Carbohydrate polymers DO - 10.1016/j.carbpol.2026.125444 UR - https://doi.org/10.1016/j.carbpol.2026.125444 ER -
APA
T, A., NF, K., A, M., R, K., Y, M., Y, M., K, K., D, K., M, O., & M, A. (2026). Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333].. Carbohydrate polymers. https://doi.org/10.1016/j.carbpol.2026.125444
Source records
- pubmed · retrieved 2026-09-27T13:21:26.500Z